Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial
Objective: To assess the incremental cost and cost-effectiveness of a restrictive versus a liberal red blood cell transfusion threshold for after cardiac surgery patients. <br/> Design: A within-trial cost-effectiveness analysis with a three month time horizon, based on a multi-centre superio...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Published: |
BMJ Publishing Group
2016
|